Osteocyte mitochondria inhibit tumor development via STING-dependent antitumor immunity
Science Advances · 19.01.2024 · 10 (3)
DOI: 10.1126/sciadv.adi4298 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 19.01.2024. Verfasst von Hao Zhou und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedic Surgery, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China. Hauptthemen laut MEDLINE: Osteocytes, Bone Neoplasms. Die Arbeit wurde bisher 50-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Bone is one of the most common sites of tumor metastases. During the last step of bone metastasis, cancer cells colonize and disrupt the bone matrix, which is maintained mainly by osteocytes, the most abundant cells in the bone microenvironment. However, the role of osteocytes in bone metastasis is still unclear. Here, we demonstrated that osteocytes transfer mitochondria to metastatic cancer cells and trigger the cGAS/STING-mediated antitumor response. Blocking the transfer of mitochondria by specifically knocking out mitochondrial Rho GTPase 1 ( Rhot1 ) or mitochondrial mitofusin 2 ( Mfn2 ) in osteocytes impaired tumor immunogenicity and consequently resulted in the progression of metastatic cancer toward the bone matrix. These findings reveal the protective role of osteocytes against cancer metastasis by transferring mitochondria to cancer cells and potentially offer a valuable therapeutic strategy for preventing bone metastasis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Orthopedic Surgery, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
- Orthopedics Research Institute of Zhejiang University, Hangzhou, Zhejiang, China.
- Key Laboratory of Motor System Disease Research and Precision Therapy of Zhejiang Province, Hangzhou, Zhejiang, China.
- Department of Orthopedics, Musculoskeletal Tumor Center, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou 310009, China.
- Department of Dermatology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
- Department of Orthopedics, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200233, China.
ORCID-Profile: Hao Zhou, Fan Xu, Tao Chen, Zenan Wang, Changqing Zhang, Junjie Gao, Zhaoming Ye
Zitieren
APA
Zhou, H., Zhang, W., Li, H., Xu, F., Yinwang, E., Xue, Y., Chen, T., Wang, S., Wang, Z., Sun, H., Wang, F., Mou, H., Yao, M., Chai, X., Zhang, J., Diarra, M. D., Li, B., Zhang, C., Gao, J., & Ye, Z. (2024). Osteocyte mitochondria inhibit tumor development via STING-dependent antitumor immunity. Science Advances, 10(3). https://doi.org/10.1126/sciadv.adi4298
Vancouver
Zhou H, Zhang W, Li H, Xu F, Yinwang E, Xue Y, et al. Osteocyte mitochondria inhibit tumor development via STING-dependent antitumor immunity. Science Advances. 2024;10(3). doi:10.1126/sciadv.adi4298
BibTeX
@article{Zhou2024,
author = {Zhou, Hao and Zhang, Wenkan and Li, Hengyuan and Xu, Fan and Yinwang, Eloy and Xue, Yucheng and Chen, Tao and Wang, Shengdong and Wang, Zenan and Sun, Hangxiang and Wang, Fangqian and Mou, Haochen and Yao, Minjun and Chai, Xupeng and Zhang, Jiahao and Diarra, Mohamed Diaty and Li, Binghao and Zhang, Changqing and Gao, Junjie and Ye, Zhaoming},
title = {Osteocyte mitochondria inhibit tumor development via STING-dependent antitumor immunity},
journal = {Science Advances},
year = {2024},
volume = {10},
number = {3},
doi = {10.1126/sciadv.adi4298}
}
EUVIMED